Search Thermo Fisher Scientific
Large-scale genotyping studies aimed at improving understanding of the genetic factors of disease risk and drug response are helping to pave the way toward precision medicine. Multi-year cohort studies and global and regional research screening initiatives are working to identify genetic effects in many different populations through genotyping analysis. To be successful, these studies require high-density SNP genotyping arrays that can provide highly accurate imputation, deliver reproducible results, and help ensure there is no loss of SNP markers from lot to lot.
Applied Biosystems now offers a family of genotyping microarrays covering SNPs, indels, and CNVs for precision medicine research and multi-population genomic studies which are highly affordable, contain high-value functional and clinical research content, and offer easy customization—all without large sample number commitments.
The Axiom Precision Medicine Diversity Array (PMDA), Axiom Precision Medicine Research Array (PMRA), and Axiom Asia Precision Medicine Research Array (Asia PMRA) are broad, powerful genotyping analysis arrays for research into common and rare inherited diseases, genetic risk profiling, immune response, pharmacogenomics, and more. They may be customized with de novo markers or markers selected from the Applied Biosystems Axiom Genomic Database of genotype-tested markers.
Need further customization? Check out our Applied Biosystems Axiom myDesign custom program.
Interested in broad pharmacogenomic coverage? Learn more about the Applied Biosystems PharmacoScan Solution.
仅供科研使用,不可用于诊断目的。